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Abstract
Bioactive chitosan microparticles can be prepared successfully by treating them with a calcium silicate solution and then subsequently
soaking them in simulated body fluid (SBF). Such a combination enables the development of bioactive microparticles that can be used
for several applications in the medical field, including injectable biomaterial systems and tissue engineering carrier systems. Chitosan
microparticles, 0.6 lm in average size, were soaked either for 12 h in fresh calcium silicate solution (condition I) or for 1 h in calcium
silicate solution that had been aged for 24 h before use (condition II). Afterwards, they were dried in air at 60 !C for 24 h. The samples
were then soaked in SBF for 1, 3 and 7 days. After the condition I calcium silicate treatment and the subsequent soaking in SBF, the
microparticles formed a dense apatite layer after only 7 days of immersion, which is believed to be due to the formation of silanol (Si–
OH) groups effective for apatite formation. For condition II, the microparticles successfully formed an apatite layer on their surfaces in
SBF within only 1 day of immersion.
" 2008 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Keywords: Apatite; Biomimetic process; Calcium silicate; Chitosan; Microparticles
1. Introduction
Organic materials have surfaces which can be tailored to
achieve different properties, such as hydrophilicity and the
capability of carrying functional groups. In addition, they
have a high degree of structural flexibility and may have
strong surface-specific binding forces, such as the ability
of their functional groups to chelate metal ions [1]. There-
fore, new strategies aim at the surface modification of
organic materials to obtain a biologically active surface
while maintaining their bulk properties. A prime example
of biomineralization would be a polymer matrix which
can be placed into a metastable solution and induce precip-
itation to occur within the polymer but not in the solution
[1]. For instance, the use of degradable polymers as matri-
ces is a major approach in the development of materials for
bone regeneration and replacement. However, biodegrad-
able materials have to degrade without an unresolved
inflammatory response or an extreme immunogenicity or
cytotoxicity [2–4].
Chitosan, a linear polysaccharide, composed of glucosa-
mine and N-acetyl glucosamine linked in a b(1–4) manner,
is one of the most abundant natural polysaccharides,
obtained from chitin by deacetylation [5–7]. The high con-
tent of primary amino groups gives chitosan unique prop-
erties, and in addition it is non-toxic, biocompatible and
degradable, which makes it very attractive for clinical uses
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[5–10]. It also has good solubility in different organic acid
solutions and sufficient resistance in alkaline solutions [11].
Synthetic biomaterials for tissue regeneration or replace-
ment have to show physical and/or biological functions in
intimate contact with hard or soft living tissue, but they are
generally non-vital and bond poorly with the host tissue
[12]. Therefore, the interface between the tissue and the
implants is not strong, and the interface detaches easily
under shear and distraction loads [13].
The biological responses of materials, such as bone
bonding, are very important in clinical applications such
as bone repair. For example, hydroxyapatite (HA), one
of the major constituents of bones and teeth [4,14,15],
has often been designated as an osteointegrating and/or
osteoconductive (i.e. bioactive) material [16]. Bioactive
HA ceramic in various forms has been used clinically dur-
ing the last few decades because of its good biocompatibil-
ity [4,14,15] and efficacy in promoting biointegration for
implants in both hard and soft tissue [17]. Moreover, the
analysis of the interface between the bone and the bioactive
implant is morphologically comparable to that of cement
lines found naturally in bone remodelling sites, and this
interfacial layer is formed on the chemically active surface
of the biomaterial, which is one of the key features of the
bonding zone and is unique to bioactive materials [18,19].
Such a type of calcium phosphate (Ca–P) layer is not
observed around materials that are not bioactive, like met-
als and polymers, when used in bone defects, implying that
the surface biomineralization of the bone mineral-like Ca–
P is a precondition of bioactivity [12]. Furthermore, for
bone replacement, a strong bonding between the host bone
and the osteoconductive surface is also required [20–23].
Chitosan itself is not able to induce the formation of an
apatite layer, i.e. it lacks bioactivity, even though it con-
tains amino and hydroxyl groups.
Bioactivity can be induced on bioinert surfaces either by
the formation of functional groups or by the formation of
thin ceramic phases that have the potential to form func-
tional groups on exposure to a body environment [24].
The key point lies in the design of a surface that is orga-
nized and functionalized so as to control the mechanisms
of heterogeneous nucleation.
For instance, it has been demonstrated [25] that by using
a simple biomimetic spraying methodology on chitosan
fibre meshes, scaffolds, produced by wet-spinning, were
able to induce the formation of a Ca–P layer when
immersed in a simulated body fluid.
It has been reported that silanol (Si–OH) groups on
polymeric materials can induce apatite formation in acellu-
lar simulated body fluids (SBF) with ion concentrations
nearly identical to those of human blood plasma [26–29].
The incorporation of Si–OH groups into the chitosan
microparticles can give bone-bonding ability to the micro-
particles, accelerating the tissue integration, which leads to
the unique strength of such interfaces. In addition, their
degradation rates make this material suitable as a bone
substitute. Furthermore, chitosan microparticles can be
easily handled during surgery, and such a mouldable
visco-elastic material or injectable bone substitute is more
easily applied than pure HA powder or granules and avoids
the migration of HA particles [11,18,30–32].
The aim of this study was to incorporate Si–OH groups
onto chitosan microparticles by soaking them in a calcium
silicate solution, in order to obtain bioactive microparticles
for designing an injectable bone substitute system.
2. Materials and methods
Chitosan (with a deacetylation degree of 87%) was
obtained from Sigma Chemical Co. (St. Louis, MO). Acetic
acid and cyclohexane were obtained from Merck (Darms-
tadt, Germany). Sodium sulphate was obtained from
Aldrich Chemical Co. (Milwaukee, WI). All the other
chemicals used were of analytical grade.
2.1. Preparation of chitosan microparticles
Chitosan microparticles were prepared by the water-in-
oil/solvent evaporation method [33]. A 50 ml quantity of
chitosan solution (0.25% (w/v), in 1% aqueous acetic acid)
containing Tween-80 (0.5 ml) was prepared by using cyclo-
hexane (75 ml) as the organic phase. Aqueous chitosan
solution was emulsified with cyclohexane in a glass beaker
(250 ml) by magnetic mixing at 1100 rpm until the forma-
tion of a milky solution (about 30 min). The stabilization
of the chitosan droplets in the emulsion was achieved by
ionic crosslinking of chitosan with sodium sulphate [33].
A sodium sulphate solution (10%, 5 ml) was added to the
suspension in a dropwise manner. The amount of sodium
sulphate needed for stabilization of chitosan microparticles
was estimated visually by premixing sodium sulphate solu-
tion with chitosan solution without cyclohexane. The vol-
ume of sodium sulphate at which turbidity began was
regarded as the ideal amount. Afterwards, the suspension
was further stirred on a magnetic stirrer for 2 h at room
temperature. Cyclohexane was removed from the emulsion
by using either rotary evaporation or slow magnetic mixing
of the suspension overnight. The chitosan particles formed
were washed by centrifuging the suspension at 8000 rpm
for 25 min using a clinical centrifuge. The microparticle
pellet was resuspended with distilled water and centrifuged
again. This procedure was repeated four times in order to
wash the chitosan particles free from the emulsifying agent
and excess sodium sulphate used in their preparation.
2.2. Calcium silicate solution treatment
In this study, the chitosan microparticles were freeze-
dried to remove the water content before the calcium sili-
cate solution treatment. Tetraethoxysilane (TEOS:
Si(OC2H5)4) (Nacalai Tesque Inc., Japan), ultrapure water,
ethyl alcohol (C2H5OH) (Nacalai Tesque Inc., Japan),
1.0 M aqueous HCl solution and calcium chloride (CaCl2)
(Nacalai Tesque Inc., Japan) were mixed for 10 min at 0 !C
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in order to prepare a calcium silicate solution with a molar
ratio of TEOS/H2O/C2H5OH/HCl/CaCl2 of 1.0/4.0/4.0/
0.014/0.20. The freeze-dried microspheres were immedi-
ately soaked in 10 ml of calcium silicate solution at
36.5 !C and 120 rpm under two conditions: condition I,
for 12 h in fresh solution; and condition II, for 1 h in the
same amount of calcium silicate solution that has been
aged for 24 h before use. The flasks were then placed in a
shaker incubator at 120 strokes min!1. The specimens were
filtered and then dried in air at 60 !C for 24 h.
2.3. Soaking in SBF
The obtained specimens were soaked in 20 ml of SBF
[26] with ion concentrations (Na+ 142.0, K+ 5.0, Ca2+
2.5, Mg2+ 1.5, Cl! 147.8, HCO!3 4.2, HPO
2!
4 1.0, SO
2!
4
0.5 mM) nearly identical to those of human blood plasma
in 70 ml polystyrene sterile flasks at 36.5 !C for different
periods up to 7 days. The SBF was prepared by dissolving
reagent-grade NaCl, NaHCO3, KCl, K2PO4 " 3H2O,
MgCl2 " 6H2O, CaCl2 and NaSO4 (Nacalai Tesque Inc.,
Japan) in distilled water, buffered at pH 7.40 with tris-
hydroxymethylaminomethane ((CH2OH)3CNH3) (Nacalai
Tesque Inc., Japan) and 1 M hydrochloric acid (Nacalai
Tesque Inc., Japan) at 36.5 !C. The flasks were put in an
incubator shacked at 120 strokes min!1. After soaking,
the specimens were removed from the SBF, washed with
distilled water and dried.
2.4. Analyses of surface and SBF
The surfaces of polymeric microparticles before and
after the solution treatments and the subsequent soaking
in SBF were analysed by the following techniques:
(i) Fourier transform attenuated total reflectance infra-
red spectroscopy (FTIR; Magna 860, Nicolet Co.,
USA) was used to analyse the chemical structure of
the polymeric microparticles before and after soaking
in the calcium silicate solution, as well as after immer-
sion in SBF (results were compared to non-immersed
controls). All spectra were recorded using at least 64
scans and 2 cm!1 resolution, in the spectral range
4000–600 cm!1.
(ii) X-ray photoelectron spectroscopy (XPS) was per-
formed on a VG ESCALAB 250iXL spectrometer.
Pressure in the analysis chamber was around
8 # 10!10 mbar. Neutralization of the surface charge
was performed by using both a low-energy flood gun
(electrons in the range 0–14 eV) and an electrically
grounded stainless steel screen placed directly on
the sample surface. The XPS measurements were car-
ried out using monochromatic Al Ka radiation
(hm = 1486.92 eV). Photoelectrons were collected
from a take-off angle of 90! relative to the sample sur-
face. The measurement was done in constant analyser
energy mode (CAE), with 100 eV for survey spectra
and 20 eV for high-resolution spectra. Charge refer-
encing was done by setting the lower binding energy
C 1s photopeak at 285.0 eV from the surface contam-
ination (adventitious carbon).
(iii) Thin-film X-ray diffraction (TF-XRD; RINT2500,
Rigaku Co., Japan) was used to identify any crystal-
line phase present on the polymeric microparticles
after soaking in the calcium silicate solution as well
as after immersion in SBF (results were compared
to non-immersed controls), and to characterize the
crystalline/amorphous nature of the apatite films.
The data collection was performed by the 2h scan
method, with 1! as the incident beam angle using a
Cu Ka X-ray line and a scan speed of 0.05! min!1
in 2h.
(iv) Field-emission scanning electron microscopy (FE-
SEM: S-4700, Hitachi Ltd., Japan) coupled to
energy-dispersive electron X-ray spectroscopy (EDS:
EMAX-7000, Horiba Ltd., Japan) was used to
observe the morphology of the polymeric microparti-
cles and to detect the calcium, phosphorous and sili-
con elements on the coating surface before and after
soaking in the calcium silicate solution and after the
subsequent soaking in SBF, for the different experi-
mental conditions and controls. Prior to EDS and
SEM analysis, sample surfaces were carbon coated
(Fisons Instruments, Evaporation PSU CA508,
UK) and gold sputtered (Fisons Instruments, Sputter
Coater SC502, UK), respectively.
2.5. Solution analysis
Element concentrations of the SBF, before and after
soaking the polymeric microparticles, were measured using
inductively coupled plasma atomic emission spectrometry
(ICP; SPS-1500VR, Seiko Instruments Inc., Japan).
3. Results
3.1. Surface structural changes of the microparticles after the
calcium silicate treatment
Fig. 1 shows FE-SEM photograph of as-prepared chito-
san microparticles. The average size of chitosan micropar-
ticles was found to be 0.6 lm. Fig. 2 shows an FE-SEM
photograph of freeze-dried chitosan microparticles.
Freeze-drying caused the chitosan microparticles to lose
their spherical morphology, with elongated thread-like
structures being produced. Similarly, the size and morphol-
ogy of freeze-dried polycaprolactone nanoparticles were
found to have changed from the original spherical shape
because of aggregation and cake formation after freeze-
drying [34]. The effect of freeze-drying on hydrogel
microparticles can be even more pronounced. Similar to
our results obtained with chitosan microparticles, typical
SEM images of gelatin microparticles, which were
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originally spherical, were observed to be irregularly shaped
string-like aggregates containing spherical domains after
freeze-drying, as shown in Fig. 1 [35].
Fig. 3 shows FTIR spectra of the surface of microparti-
cles subjected to the calcium silicate treatment under condi-
tion I or II.
Before the calcium silicate treatment, two main reflec-
tion peaks of chitosan were observed, at 1620 and
1524 cm!1, which were ascribed to amide I and amide II,
respectively. After the calcium silicate treatment under
both conditions, new reflection peaks of silanol (Si–OH)
groups and siloxane (Si–O–Si) groups were observed.
Reflection peaks of Si–OH groups are typically observed
for silica gels [36]. Condition II gave higher intensities of
the Si–O–Si peak at $1089 cm!1 than did condition I. This
can be attributed to the better polycondensation of TEOS
in the calcium silicate solution under condition II than
under condition I. The bands at $3673 and $2979 cm!1
can be attributed to the hydroxyl (–OH) groups present
in the structure of chitosan [36,37], while the bands which
lie in the range 3680–3075 cm!1 can be ascribed to the –
OH groups after the calcium silicate treatment, indicating
that TEOS was completely hydrolysed into Si–OH groups
[36]. Additionally, the reflection peaks of amide I and
amide II were still observed even after the calcium silicate
treatment.
Table 1 shows the atomic concentrations, calculated
from XPS spectra, and the corresponding atomic values
for chitosan microparticles, before and after calcium sili-
cate treatment under condition I or II.
The XPS peak ratios show progressive disappearance of
the underlying substrate signals (C1s and N1s) and the
appearance of peaks of Si2p and Ca2p for conditions I
and II (Table 1). In addition, there is a clear increase in
oxygen content after the calcium silicate treatment. For
condition II, the increase in silicon content was higher than
for condition I.
Upon calcium silicate treatment, the relative C/Si ratio
of the chitosan microparticles was 1.7 and 1.6 for condi-
tions I and II, respectively.
3.2. Surface structural changes of the microparticles in SBF
After soaking in SBF, FTIR analysis was performed in
order to characterize the chemical structure of the obtained
calcium phosphate under the different conditions. Fig. 4
shows the FTIR spectra of the surface of microparticles
subjected to the calcium silicate treatment under condition
I or II and subsequently soaked in SBF up to 7 days.
After soaking in SBF for 1 day, reflection peaks of the
phosphate group ðPO3!4 Þ (around 1028 and 1012 cm!1)
were observed for both conditions. However, comparing
both spectra, it was noted that the intensity of this peak
under condition II was strong and appeared along with a
well-defined band at 1012 cm!1 (see Fig. 4b) [38]. As the
soaking time in SBF increases, the phosphate band
becomes sharper.
Fig. 5 shows TF-XRD patterns of the surfaces of chito-
san microparticle treated with a calcium silicate solution
under condition I or II and subsequently soaked in SBF
up to 7 days.
Calcium sulphate (CaSO4 " 0.5H2O, ASTM JCPDS 45-
0848) was partially formed on the surface of the chitosan
microparticles after the calcium silicate treatment under
both conditions I and II. The TF-XRD patterns of the sur-
face of chitosan microparticles treated with a calcium sili-
cate solution under condition II exhibit two broad
diffraction peaks, which, from their positions and intensi-
ties, can be assigned to an apatite-like phase (ASTM
JCPDS 9-432) after soaking in SBF for only 1 day (see
Fig. 5b), whereas that treated with a calcium silicate under
condition I showed them after soaking in SBF for 7 days
(see Fig. 5a). The peaks at 25.87! and 31.78! in 2h corre-
sponded to (002) and (211) diffraction planes of apatite,
respectively. With further soaking time in SBF, new diffrac-
Fig. 1. SEM micrographs of the surface of prepared chitosan
microparticles.
Fig. 2. SEM microphotographs of the surface of chitosan microparticles
after freeze-drying.
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tion peaks appeared, namely, 39.82! and 46.71! in 2h, cor-
responding to (310) and (222) diffraction planes of apatite
(see Fig. 5b).
Figs. 6 and 7 show FE-SEM images and EDS spectra
of the surface of microparticles, untreated and treated
with calcium silicate solution under conditions I and II,
then soaked in SBF for 1, 3 and 7 days. After the soak-
ing in the calcium silicate solution, tiny needle-like crys-
tals were formed on the surface of the microparticles.
This surface structural change was brought about by
modification with calcium silicate. When the chitosan
microparticles treated with a calcium silicate solution
under condition I were soaked in SBF for up to 7 days,
the microparticles were completely covered with a uni-
form and dense apatite layer (see Fig. 6a), which is in
agreement with the TF-XRD patterns in Fig. 5a. After
1 day, only the formation of calcium phosphate nuclei
was observed; these nuclei increased in both number
and size with increasing soaking time in SBF, and coa-
lesced to form an apatite layer after 7 days.
For condition II, the chitosan microparticles showed the
ability to induce the formation of an apatite layer within
only 1 day in SBF (see Fig. 6b). This layer became more
dense and compact with increasing soaking time in SBF.
Moreover, at higher magnifications, we observed a finer
structure where needle-like crystals were agglomerated.
By EDS measurement, the presence of elemental sulfur
(S) was detected on the surface of untreated chitosan
microparticles, which came from the stabilization reagent
of the chitosan microparticles (see Fig. 7). After the cal-
cium silicate treatment under conditions I and II, apprecia-
ble quantities of silicon (Si), S, chlorine (Cl) and calcium
(Ca) were detected on the surface of the chitosan micropar-
ticles (see Fig. 7a and b), which is in good agreement with
the detection of calcium sulphate (CaSO4 " 0.5H2O) in the
TF-XRD patterns in Fig. 5.
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Fig. 3. FTIR spectra of the surfaces of chitosan microparticles treated with a calcium silicate solution under condition I or II.
Table 1
Atomic concentrations and corresponding atomic ratios (calculated from
XPS spectra) of chitosan microparticles before and after treatment with a
calcium silicate solution under condition I (12 h of immersion) or II (1 h of
immersion in the solution that has aged for 24 h before using)
Material Atomic concentration (%) C/Si
ratioC1s O1s N1s S2p Si2p Ca2p
Chitosan microparticles
(untreated)
68.3 26.2 3.5 1.9 – – –
Condition I 27.9 44.0 1.2 5.4 16.3 3.6 1.7
Condition II 26.1 46.8 1.1 4.7 17.4 3.0 1.5
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The peak intensities of Ca and Si under condition I were
higher and lower, respectively, than under condition II.
Also, the peak intensity of Cl under condition I was higher
than under condition II. After soaking in SBF for 7 days,
strong peaks ascribed to Ca and phosphorus (P) were
detected (see Fig. 7a). When the microparticles were treated
with a calcium silicate solution under condition II, a signif-
icant quantity of Ca and P was detected after only 1 day in
SBF (see Fig. 7b). The intensity of Ca and P peaks
increased significantly with increasing soaking time in
SBF. These results are in good agreement with those
obtained from the TF-XRD analysis in Fig. 5b.
Fig. 8 shows the changes in calcium, phosphorus and sil-
icon concentrations of SBF in which chitosan microparti-
cles treated with a calcium silicate solution under
condition I or II were soaked for various periods up to 7
days.
For both conditions I and II, the calcium concentration
increased in the initial 24 h in SBF due to the release of cal-
cium ions from the surface of the specimen into SBF,
although this increase was higher for condition I than for
condition II. As for the phosphorus concentration, there
was a remarkable decrease with increasing soaking time.
This decrease was more pronounced for condition I. Fur-
thermore, an appreciable increase in silicon concentration
was observed for both conditions. However, this increase
was slightly accentuated for the microparticles treated with
a calcium silicate solution under condition II. As the soak-
ing time in SBF increase, a decrease in calcium and phos-
phorus concentrations was observed. On the other hand,
no change was observed in the calcium and phosphorus
concentrations for the untreated chitosan microparticles
because, as mentioned above, chitosan does not have apa-
tite-forming ability in SBF.
4. Discussion
Recently, much attention [8,9,39–50] has been focused
on the use of natural origin polymers, like polysaccharides,
such as starch, chitin and chitosan, and others, such as soy
proteins and casein, because they are widely available in
nature, cost-effective, biodegradable and non-toxic. Fur-
thermore, chitosan has recently drawn considerable interest
due to its favourable biological properties over other poly-
mers [5,6,8–10,25,51,52]. Therefore, it is a polymer that
exhibits many interesting properties, such as low toxicity,
biocompatibility and biodegradability [5,6,8–10,51,52].
The most important feature of chitosan is its hydrophilicity
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Fig. 4. FTIR spectra of the surfaces of chitosan microparticles treated with a calcium silicate solution under condition I or II and subsequently soaked in
SBF for 1, 3 and 7 days.
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and its high content of primary amino groups, which make
this polymer rather unique. However, the presence of these
groups does not confer a bioactivity character to the chito-
san, which limits its use for bone related applications.
These statements are in agreement with the results of
Tanahashi et al. [53], who found that these groups have
quite a weak apatite nucleating ability, i.e. they require
soaking in SBF for a period longer than 7 days.
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Fig. 5. TF-XRD patterns of the surfaces of chitosan microparticles treated with a calcium silicate solution under condition I or II and subsequently
soaked in SBF for 1, 3 and 7 days.
Fig. 6. SEM photographs of the surface of chitosan microparticles treated with a calcium silicate solution under condition I or II and subsequently soaked
in SBF for 1, 3 and 7 days.
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In this study, when chitosan microparticles were soaked
in a calcium silicate solution, Si–OH groups formed on
their surface, and these have the ability to induce the for-
mation of an apatite layer. Such a novel system can be used
as an injectable bone substitute, although the mechanical
properties are not ideal. To over knowledge, such a type
of coating method has never been used on chitosan.
As shown in Fig. 2, in the present study, we used the
freeze-dried chitosan microparticles with irregular shapes.
For injectable biomaterials, a spherical shape is more
advantageous as their geometry allows them to be delivered
more easily through needles. For that reason, the optimiza-
tion of freeze-drying of chitosan microparticles will be
investigated further with the use of cryoprotective agents
to prevent aggregation and preserve the spherical morphol-
ogy during drying.
As shown in Figs. 5 and 6, the microparticles treated
with calcium silicate solution under conditions I and II
formed apatite on their surfaces within 7 days and 1 day
in SBF, respectively. The number of Si–OH groups, effec-
tive in inducing apatite nucleation [27,29,54–56], on the
microparticles before soaking in SBF was different between
the two conditions (see Fig. 3). These differences might be
attributed to the further progress of hydrolysis and poly-
condensation of TEOS in the calcium silicate solution
due to an aging period, such as the 24 h in condition II.
Such an aging period leads to an increase in the oxygen
and silicon contents on the surface of the chitosan micro-
particles, which is in agreement with the XPS results; the
C/Si ratio was also higher for condition II than for condi-
tion I (see Table 1). Therefore, the chitosan microparticles
under condition II had more Si–OH available for the
induction of an apatite coating. The hydrolysis and poly-
condensation of TEOS in the calcium silicate solution
was not fully completed for condition I. In addition, these
results are in agreement with those obtained from FTIR
measurement (see Fig. 3), since the presence of Si–O–Si
and Si–OH bands as well as their intensities were stronger
for the calcium silicate treatment under condition II than
under condition I. Moreover, the chitosan microparticles
were soaked in the calcium silicate solution for 12 h under
condition I. Such a long soaking time in the calcium silicate
solution only caused the adsorption of a large amount of
Si, Ca and Cl on the chitosan surface due to the higher
hydrophilicity of chitosan, as shown in Fig. 7a.
From the ICP results showed in Fig. 8, when the chito-
san microparticles were treated with calcium silicate solu-
tion under condition I, they showed the largest calcium
concentration increase in the initial 24 h in SBF solution.
This might be because chitosan has the water-uptake prop-
erties to allow the adsorption of a large amount of calcium
ions from the calcium silicate solution, and hence the
microparticles released a fairly large amount of calcium
ions into the SBF during soaking. Also, an accentuated
decrease of the phosphorus concentration was observed,
which may be due to the interaction between the amino
groups in the chitosan structure and the phosphate ions
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Fig. 7. EDS profiles of the surface of chitosan microparticles, which were
treated with a calcium silicate solution under condition I or II and
subsequently soaked in SBF for 1, 3 and 7 days.
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present in the SBF solution. On the other hand, such a
decrease is related with apatite formation. For condition
II, only a small increase in the calcium concentration was
observed during the initial 24 h in SBF, since the chitosan
microparticles consumed the released calcium ions to form
apatite on their surfaces within 1 day. The release of silicon
was slightly higher under condition II than under condition
I, which means that the calcium silicate layer formed under
condition II dissolved into SBF more rapidly than under
condition I. The release of silicon is attributed to the disso-
lution of silicon ions from the calcium silicate layer, which
results in the formation of the Si–OH groups that are
responsible for the apatite nucleation.
These results indicate that the amount of Si–OH groups
can be speculated by two parameters: the rate of the disso-
lution of the silica into the SBF, because the dissolution of
the silica gel, in this case calcium silicate gel, proceeds via
the hydrolysis of silica [27,28]; and the aging period of
the calcium silicate solution. Since the aging period in the
calcium silicate solution under condition II was 24 h, it
led to better hydrolysis and polycondensation of TEOS
in the calcium silicate solution. Furthermore, the soaking
time of only 60 min in this solution was enough to produce
a relatively high density of Si–OH on the chitosan micro-
particles surface, which is a prerequisite for apatite forma-
tion in the body environment. These results are in
agreement with the FTIR, XPS and EDS analyses (see
Table 1 and Figs. 3 and 7b).
When the calcium silicate-coated microparticles were
soaked in SBF, the calcium ions in the calcium silicate layer
were released into the SBF to form many Si–OH groups
and simultaneously increased the ionic activity product of
the surrounding fluid with respect to apatite. The Si–OH
groups induce apatite nucleation, and the increased ionic
activity product accelerates the nucleation rate of apatite.
Once apatite nuclei are formed, they can grow into a uni-
form layer by consuming the calcium and phosphate ions
from the SBF, since the SBF is already highly supersatu-
rated with respect to apatite [57]. This is supported by
the results obtained by the measurements of calcium and
phosphorus concentrations of SBF shown in Fig. 8. On
the other hand, in terms of chemical bonding between Si–
OH and apatite, we can speculate that the Si–OH group
may have a negative charge (Si–O!) in the SBF according
to the isoelectric point of SiO2 (around pH 2.5). The Si–O
!
formed may interact with positively charged Ca2+ ions to
form a Ca-rich positive thin layer, and finally combine with
negatively charged PO3!4 ions to form amorphous calcium
phosphate, which transforms into apatite in SBF [58].
Therefore, we can speculate that some chemical bonding
such as Si–O–Ca–O–Si exists at the interface between apa-
tite and calcium silicate.
By incorporating Si–OH groups into the chitosan micro-
particles, it is thus possible to have a biodegradable mate-
rial with bone-bonding properties, which can therefore
promote healing at a faster rate, leading to the unique
strength of such interfaces. This material would ultimately
enhance the repair/regeneration several-fold, and ulti-
mately improve patient compliance and comfort. The
development of such material has several advantages com-
pared with other systems [30–32], including water-uptake
and swelling properties, its easily application during sur-
gery, flexibility to fill various types of bone defect sites with
closer packing, which provides a good osteointegration,
and also the biodegradability of these microparticles, which
is a further advantage as no surgical removal of the implant
is needed. Such properties make this material suitable for
bone substitutes in the orthopaedic field. Moreover, due
to the cationic nature of chitosan and predictable degrada-
tion rate, these microparticles can also have the potential to
incorporate a therapeutic agent and release them in a con-
trolled fashion. Therefore, the combination of the biodeg-
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radation and osteoconduction properties of these micro-
particles with the possible release of a bioactive agent make
it promising as an injectable bone substitute and at same
time a controlled release drug delivery system [59].
5. Conclusions
The growth of a bonelike apatite layer on chitosan
microparticles after a calcium silicate treatment was suc-
cessfully achieved in SBF within 1 day. Moreover, it was
shown that the incorporation of Si–OH groups and the
water-uptake properties of chitosan, which allow it to
absorb calcium ions from the calcium silicate solution by
the present method, give it the ability to induce the forma-
tion of an apatite layer. In this sense, these biodegradable
microparticles maximize the osteoconductive behaviour
with the presence of Si–OH groups, which allow bone
ingrowth into the implant to occur as the microparticles
are resorbed with time. The use of degradable polymers
as microparticles forms a major approach in the develop-
ment of bone substitutes when compared to the nondegrad-
able systems. Therefore, combining all the properties of
these chitosan microparticles – biodegradability, osteocon-
ductivity and mouldablity – it is possible to have an inject-
able biomaterial system that can also act as a drug delivery
system.
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